4.3 Article

Cancer Stem Cells as a Predictive Factor in Radiotherapy

期刊

SEMINARS IN RADIATION ONCOLOGY
卷 22, 期 2, 页码 151-174

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.semradonc.2011.12.003

关键词

-

资金

  1. Deutsche Forschungsgemeinschaft [KU971/7-1, BA1433]
  2. MRC [G0700730]
  3. NIHR Biomedical Research Centre, Oxford
  4. BMBF Center for Innovation Competence
  5. MRC [G0700730] Funding Source: UKRI
  6. Medical Research Council [G0700730] Funding Source: researchfish

向作者/读者索取更多资源

Cancer stem cell research is one of the most thriving and competitive areas in oncology research because it has the potential to dramatically affect clinical outcomes. Led by progress in hematology, cancer stem cell research has now provided evidence to play an important role for solid cancers as well. Because radiotherapy is only second to surgery in terms of its curative potency, it is very important for radiation oncologists to learn whether progress in cancer stem cell biology can enable them to exploit this knowledge to help cure more patients suffering from cancer. The present article gives an overview about the challenges of the cancer stem cell concept and highlights some important phenomena that are under intense investigation, such as phenotypic plasticity of sternness and impact and dynamics of microenvironmental niches. We discuss the potential and limitations of current experimental and theragnostic tools and end up with an agenda for future research as outlook for translational possibilities in the clinic. Semin Radiat Oncol 22:151-174 (c) 2012 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据